Making a cell product, meeting its quality requirements, shipping it and treating a person are different outcomes. A report's definition and denominator determine what its success rate means.
A process can stop without a product, produce a nonconforming lot, make a conforming product that is never shipped, or supply material that is never infused. Out-of-specification means at least one stated requirement was missed; it does not determine which attribute, severity or disposition applies. Studies sometimes include such lots within manufacturing failure, while others report separate categories. Keep orders, collections, runs, batches, people, cancellations and follow-up with the reported measure.
Shares Cryopreservation and cell-therapy cold chain, Cell-therapy release and potency testing, Autologous CAR-T manufacturing, batch by batch, Allogeneic (off-the-shelf) cell therapy.
Shares Vein-to-vein time and manufacturing slots, Apheresis (leukapheresis), Allogeneic (off-the-shelf) cell therapy.
Shares Vein-to-vein time and manufacturing slots, Cell-therapy release and potency testing.
Shares Vein-to-vein time and manufacturing slots, Cell-therapy release and potency testing.
Shares Apheresis (leukapheresis), Cryopreservation and cell-therapy cold chain, Autologous CAR-T manufacturing, batch by batch.
Shares Cryopreservation and cell-therapy cold chain, Allogeneic (off-the-shelf) cell therapy.
Shares Vein-to-vein time and manufacturing slots, Cell-therapy release and potency testing.
Shares Vein-to-vein time and manufacturing slots, Cell-therapy release and potency testing, Autologous CAR-T manufacturing, batch by batch.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/